Investor Presentation 2021
A research-driven innovation process
Supported by unrivalled capabilities & innovation
>
› 69
Creation and
application
Centres
-0000-
over
122,600
CHF 536 mln
Products sold
per year
R&D spend in
2020
over 500
Employees in
Science &
Technology
> over 3,600
Active
patents
Innovation initiatives and priorities
༤
Supplier enabled
innovation
partnerships with
bioscience companies
Delivering differentiating
technologies and solutions in
Flavours, nutritional and
functional ingredients (clean
label delivery systems, health
and wellbeing solutions etc.)
Enabling novel consumer
experiences in Fragrances:
naturals, new sensory
experiences, sustainable
new molecules and
precursors etc.
Givaudan
Investor presentation 2021
updated May 2021
10View entire presentation